HCA Healthcare (HCA) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
6 May, 2026Opening remarks and agenda
The meeting was held virtually, with the agenda and rules available online.
Formal proceedings included director elections, auditor ratification, executive compensation, and two shareholder proposals.
Board and executive committee updates
Nine director nominees were introduced, including several external executives and internal leaders.
Robert Dennis was recognized for his service as he retired from the board.
Doug Rohleder of Ernst & Young LLP was introduced as the independent auditor.
Shareholder proposals
A proposal for a report on healthcare consequences at Mission Hospital was presented, citing patient safety, staffing, and reputational risks; the board recommended voting against it.
A proposal to allow shareholders to act by written consent was presented, with arguments for increased shareholder rights; the board opposed it.
Latest events from HCA Healthcare
- Q2 2026 revenue up 8.7%, EPS up 11%, but uninsured admissions surged and pressured margins.HCA
Q2 202628 Jul 2026 - Q3 revenue and net income rose sharply, but hurricane impacts will weigh on full-year results.HCA
Q3 20248 Jul 2026 - Strategic execution, AI, and disciplined investment drive growth amid regulatory and exchange headwinds.HCA
2026 KeyBanc Capital Markets Healthcare Forum8 Jul 2026 - 2024 delivered robust growth and resilience, with 2025 guidance signaling continued strength.HCA
Q4 20248 Jul 2026 - Q1 2026 revenue rose 4.3% to $19.1B, net income $1.62B, and guidance was reaffirmed.HCA
Q1 20268 Jul 2026 - Q1 2025 saw 5.7% revenue growth, higher EPS, strong capital returns, and reaffirmed guidance.HCA
Q1 20258 Jul 2026 - AI, network expansion, and tech upgrades drive efficiency amid regulatory and margin pressures.HCA
47th Annual Raymond James Institutional Investor Conference8 Jul 2026 - Record 2025 growth and strong 2026 outlook, with stable margins and major investments planned.HCA
Q4 20258 Jul 2026 - Strong volume growth, stable costs, and robust capital deployment drive positive outlook.HCA
UBS Global Healthcare Conference8 Jul 2026 - EBITDA headwinds from APTC expiration are manageable; growth and innovation initiatives remain on track.HCA
RBC Capital Markets Global Healthcare Conference 202620 May 2026